Combination studies investigating dual amylin/incretin receptor activation are gaining research interest for their potential synergistic metabolic effects
Common side effects reported by the Mayo Clinic include: Diarrhea Headache Nausea If these side effects become severe or troublesome, let your healthcare provider know immediately
TB-500 is a synthetic peptide modeled after the naturally occurring protein Thymosin Beta-4 (T4)
Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Laboratory methods included HPLC ( n = 4), LC-MS/MS ( n = 3), ELISA ( n = 3), and LC-UV-MS ( n = 1)